Patrick Wen

Patrick Wen is Director of the Center For Neuro-Oncology at the Dana-Farber Cancer Institute and Professor of Neurology at Harvard Medical School. Dr. Wen is also chair of the Dana-Farber/Harvard Cancer Center Neuro-Oncology Clinical Trials Committee and principal or co-investigator of many ongoing clinical protocols. Dr. Wen's clinical research focuses on targeted molecular therapies and anti-angiogenic therapies for gliomas, meningiomas, and brain metastases. He serves on numerous national and international committees, including the NCI Developmental Therapeutics and the Cancer Diagnostic and Treatment SBIR Study Sections and co-chairs the American Brain Tumor Consortium New Agents Committees. He is Editor-in-Chief for the Journal of Neuro-Oncology and on the editorial board of Clinical Cancer Research. He is Chair of the Medical Advisory Board for the National Brain Tumor Society.